Risk of Share-Value Dilution from the Exercise of Stock Acquisition Rights
First written in FY2018. 21 of 23 entries say "Materialised", first in FY2019-Q2. Latest entry: FY2026-H1.
GAtechnologies moved to the "Worse" side of this theme in 2019, 2 years before the typical company in this theme (2021).
The whole theme swung hardest in 2017: 28 of 54 companies on the "Worse" side.
56 other companies' latest entry also says "Materialised".
- FY2026-H1MaterialisedAnnual report
「1 November 2025–30 April 2026 (Note) 7,560 41,053,315 4 9,967 4 12,607 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the six-month period, the exercise of stock acquisition rights resulted in the issuance of 7,560 shares, with part of the dilution materializing as an actual share issuance. - 2026-03-17MaterialisedEarnings
「Issuance of new shares (exercise of share acquisition rights)」
New shares were issued through the exercise of stock acquisition rights during the first quarter of the current consolidated cumulative period, increasing the number of shares outstanding from 41,045,755 in the fiscal year ended October 2025 to 41,056,915. - FY2025-H1MaterialisedAnnual report
「1 November 2024–30 April 2025 (Note) 2 22,680 41,011,615」
During the six-month period, the exercise of stock acquisition rights resulted in the issuance of 22,680 shares, with part of the potential dilution materializing as an actual share issuance. - FY2024-Q1MaterialisedAnnual report
「1 November 2023–31 January 2024 (Note) 1 11,520 36,762,735 1 7,264 1 9,903 (Note) 1. Increase resulting from the exercise of stock acquisition rights.」
During the first quarter, the exercise of stock acquisition rights resulted in the issuance of 11,520 shares. The issuance of a further 2,280 shares in February 2024 before the filing date was also disclosed. - FY2023-Q3MaterialisedAnnual report
「Increase resulting from the exercise of stock acquisition rights 123,740」
During the nine-month period, the exercise of stock acquisition rights resulted in the issuance of 123,740 shares, with part of the dilution materializing as an actual share issuance. The issuance of a further 4,680 shares in August 2023 before the filing date was also disclosed. - FY2023-Q2MaterialisedAnnual report
「24 February 2023–27 April 2023 (Note) 89,060 36,746,535 17 7,261 17 9,901 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the six-month period, the exercise of stock acquisition rights resulted in the issuance of 89,060 shares, with part of the dilution materializing as an actual share issuance. - FY2023-Q1MaterialisedAnnual report
「14 November 2022–20 December 2022 (Note) 1 34,680 36,657,475 5 7,243 5 9,883 (Note) 1. Increase resulting from the exercise of stock acquisition rights.」
During the first quarter, the exercise of stock acquisition rights resulted in the issuance of 34,680 shares, with part of the dilution materializing as an actual share issuance. - FY2022MaterialisedAnnual report
「10 November 2021–13 October 2022 Common shares 227,020 shares Increase resulting from the exercise of stock acquisition rights.」
During the fiscal year, the exercise of stock acquisition rights resulted in the issuance of 227,020 shares, with part of the dilution materializing as an actual share issuance. The issuance of a further 34,680 shares after November 2022, before the filing date, was also disclosed. - FY2022-Q3MaterialisedAnnual report
「1 May 2022–31 July 2022 (Note) 2 6,000 36,437,175 0 7,225 0 9,865 (Note) 2. Increase resulting from the exercise of stock acquisition rights. 3. Between 1 August 2022 and 31 August 2022, the exercise of stock acquisition rights increased the total number of shares issued and outstanding by 176,640 shares, while capital stock and the capital reserve each increased by ¥6 million.」
During the third quarter, the exercise of stock acquisition rights resulted in the issuance of 6,000 shares, followed by the issuance of a further 176,640 shares in August 2022 before the filing date. - FY2022-Q2MaterialisedAnnual report
「Increase resulting from the exercise of stock acquisition rights 35,400」
During the six-month period, the exercise of stock acquisition rights resulted in the issuance of 35,400 shares, with part of the potential dilution materializing as an actual share issuance. - FY2022-Q1MaterialisedAnnual report
「10 November 2021–20 January 2022 (Note) 1 8,640 35,161,015 0 7,220 0 8,816 (Note) 1. Increase resulting from the exercise of stock acquisition rights.」
During the first quarter, the exercise of stock acquisition rights resulted in the issuance of 8,640 shares, with part of the dilution materializing as an actual share issuance. - FY2021MaterialisedAnnual report
「(5) Issuance of 341,160 new shares upon the exercise of the first, second, third and fourth series of stock acquisition rights」
During the fiscal year, the exercise of stock options resulted in the issuance of 341,160 shares, with part of the dilution materializing as an actual share issuance. - FY2021-Q3MaterialisedAnnual report
「Between 1 August 2021 and 31 August 2021, the exercise of stock acquisition rights increased the total number of shares issued and outstanding by 152,760 shares, while capital stock and the capital reserve each increased by ¥5 million.」
The exercise of stock acquisition rights in August 2021, before the filing date, resulted in the issuance of 152,760 shares, with part of the dilution materializing as an actual share issuance. - FY2021-Q1MaterialisedAnnual report
「9 November 2020–8 January 2021 44,040 29,437,155 6 1,188 6 2,026 (Note) 2. Increase resulting from the exercise of stock acquisition rights.」
During the first quarter, the exercise of stock acquisition rights resulted in the issuance of 44,040 shares, with part of the potential dilution materializing as an actual share issuance. - FY2020MaterialisedAnnual report
「1 March 2020–31 October 2020 Common shares 194,920 shares Increase resulting from the exercise of stock acquisition rights.」
During the fiscal year, the exercise of stock acquisition rights resulted in the issuance of 194,920 shares. Meanwhile, the seventh series of stock acquisition rights expired when the exercise period ended on 19 February 2020. - FY2020-Q3MaterialisedAnnual report
「1 May 2020–31 July 2020 (Note) 1 3,320 9,690,225 0 1,168 0 2,006 (Note) 1. Increase resulting from the exercise of stock acquisition rights. 2. Between 1 August 2020 and 31 August 2020, the total number of shares issued and outstanding increased by 22,640 shares through the exercise of stock acquisition rights, while capital stock and the capital reserve each increased by ¥3 million.」
During the third quarter, the exercise of stock acquisition rights resulted in the issuance of 3,320 shares, followed by the issuance of a further 22,640 shares in August 2020. - FY2020-Q2MaterialisedAnnual report
「1 February 2020–30 April 2020 (Note) 84,120 9,686,905 7 1,168 7 2,006 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the second quarter, the exercise of stock acquisition rights resulted in the issuance of 84,120 shares, with part of the dilution materializing as an actual share issuance. - FY2020-Q1MaterialisedAnnual report
「1 November 2019–30 November 2019 47,080 (Note) 1. Increase resulting from the exercise of stock acquisition rights.」
The exercise of stock acquisition rights in November 2019 resulted in the issuance of 47,080 shares, with part of the potential dilution risk materializing as an actual share issuance. - FY2019MaterialisedAnnual report
「As of the end of the month preceding the filing date of this document, the number of potential shares represented by stock acquisition rights was 997,560, equivalent to 10.5% of the total 9,479,935 shares issued and outstanding.」
While disclosing the actual issuance of 724,760 shares through the exercise of stock acquisition rights, 997,560 potential shares, equivalent to 10.5% of shares issued and outstanding, remained as of the end of the month preceding the filing date. - FY2019-Q3MaterialisedAnnual report
「During the quarter, stock acquisition rights relating to bonds with stock acquisition rights subject to a provision for adjustment of the exercise price and other instruments were exercised as follows. Number of shares delivered upon exercise during the quarter (shares) 609,000 Funds raised through exercises during the quarter (¥ thousand) 2,087,393」
Exercises of the sixth and seventh series of stock acquisition rights progressed, and 609,000 shares were delivered during the third quarter. Part of the potential dilution risk has materialized as an actual share issuance. - FY2019-Q2MaterialisedAnnual report
「(Note) Between 1 May 2019 and 31 May 2019, the total number of shares issued and outstanding increased by 100,560 shares through the exercise of stock acquisition rights, while capital stock and the capital reserve each increased by ¥9,176 thousand.」
The exercise of stock acquisition rights resulted in the actual issuance of 100,560 shares, with part of the potential dilution risk materializing as an actual share issuance. - FY2019-Q1WorsenedAnnual report
「Potential shares from the issuance: 870,000 shares (100 shares per stock acquisition right)」
The issuance and payment for the sixth and seventh series of stock acquisition rights have been completed, and an additional 870,000 potential shares have been disclosed, increasing the potential exposure to dilution of equity value. - FY2018First statedAnnual report
「As of the filing date of this document, the number of potential shares represented by stock acquisition rights was 1,005,400, equivalent to 11.8% of the total 8,502,760 shares issued and outstanding.」
Quantifies the potential dilution from the exercise of stock acquisition rights as 1,005,400 potential shares, or 11.8% of total shares issued and outstanding.